Versor Investments LP Seagen Inc. Transaction History

Versor Investments LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$191.51 - $216.16 $8.07 Million - $9.11 Million	-42,124 Reduced 56.28%	32,719 $6.94 Million
Q2 2023 Aug 07, 2023	BUY	$187.64 - $206.25 $9.01 Million - $9.91 Million	48,042 Added 179.25%	74,843 $14.4 Million
Q1 2023 May 05, 2023	BUY	$127.59 - $203.08 $3.42 Million - $5.44 Million	26,801 New	26,801 $5.43 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

Stay updated on Versor Investments LP with notifications on news.